Gimv NV (GIMB.BR) Bundle
Who's buying Gimv NV and why matters now more than ever: cornerstone investor WorxInvest NV controls a commanding 35.44% stake - 13,044,532 shares as of July 30, 2025 - while institutional players like The Vanguard Group (≈2.58%, 949,792 shares worth €41.2m), Dimensional Fund Advisors (1.85%, 682,749 shares, +4.45%), Norges Bank IM (1.48%, 544,553 shares), BlackRock (0.98%, 359,401 shares, a striking +111% increase) and Candriam (0.9%, 332,163 shares) shape the shareholder base; these ownership stakes sit against a company with a market cap of €1.6 billion, a share price of €43.60 (12 Dec 2025), FY 2024-25 net income of €219 million, NAV per share of €53.3 and an attractive dividend yield of 5.96% (ex-dividend 30 June 2025), while an 82% Buy consensus and €49.98 average target alongside inclusion in the Euronext BEL ESG index and a diversified portfolio across Consumer, Sustainable Cities, Smart Industries, Healthcare and Life Sciences explain why different investor types-activist, passive, value and ESG-focused-are piling in or holding steady; read on to unpack how each major shareholder's moves and these metrics could shape Gimv's next chapter
Gimv NV (GIMB.BR) - Who Invests in Gimv NV and Why?
Gimv NV attracts a mix of strategic majority holders, large institutional investors, and asset managers drawn to its private equity exposure, long-term NAV growth potential and dividend policy. Below is a snapshot of the largest known investors, their stakes, and recent changes in holdings.| Investor | Stake (%) | Shares | Market Value (€) | Recent Change | Notes / Motivation |
|---|---|---|---|---|---|
| WorxInvest NV | 35.44% | 13,044,532 | - | Position following capital increases & purchases (as of 30 Jul 2025) | Strategic/controlling investor with long-term influence on governance and capital plan |
| The Vanguard Group, Inc. | 2.58% | 949,792 | €41.2m | +0.5% stake | Index/passive exposure to Belgian equities and exposure to private equity-lite via listed vehicle |
| Dimensional Fund Advisors LP | 1.85% | 682,749 | €29.6m | +4.45% holdings | Factor/quant strategies adding selective exposure as NAV and earnings trajectory improve |
| Norges Bank Investment Management | 1.48% | 544,553 | €23.6m | No change | Sovereign wealth / long-term benchmark holdings in developed-market equities |
| BlackRock, Inc. | 0.98% | 359,401 | €15.6m | +111% holdings | Active and ETF flows increasing exposure amid valuation or liquidity signals |
| Candriam, Société En Commandite Par Actions | 0.90% | 332,163 | €14.4m | No change | European asset manager keeping a steady position for client mandates |
- Majority/strategic holder: WorxInvest NV's 35.44% holding (13,044,532 shares) gives it effective control and influence over capital decisions, M&A appetite and board composition.
- Index & passive investors: Vanguard's ~2.58% stake provides stable, long-term shareholding linked to passive product flows.
- Quant / factor funds: Dimensional's increased stake (1.85%, +4.45%) suggests model-driven accumulation on valuation/quality signals.
- Sovereign / long-horizon investors: Norges Bank's steady 1.48% shows benchmarked, low-turnover ownership.
- Large asset managers & ETF providers: BlackRock's 111% rise to 0.98% indicates reallocation or ETF-driven demand for listed private equity exposure.
- Active European managers: Candriam's steady 0.9% reflects buy-and-hold client mandates seeking diversified European equity exposure.
Institutional Ownership and Major Shareholders of Gimv NV (GIMB.BR)
As of July 30, 2025, Gimv NV's shareholder base is dominated by a mix of strategic anchors and global asset managers. Concentration is significant: WorxInvest NV is the controlling shareholder, while a cohort of large international funds hold the next largest positions, each reflecting distinct investment motives (long-term strategic exposure, index/ETF tracking, factor/quant strategies, and active private equity conviction).
- Largest strategic/insider holder: WorxInvest NV - concentrated control and alignment with Gimv's long-term private equity model.
- Passive and index-linked holders: The Vanguard Group and Norges Bank - provide stable, low-turnover ownership.
- Quant and factor investors: Dimensional Fund Advisors and BlackRock (partly via factor/ETF products) - show dynamic allocation changes.
- Specialized European managers: Candriam - targeted exposure to European mid-market growth and sustainability themes.
| Shareholder | % Ownership | Shares Held | Estimated Value (€) | Recent Stake Change |
|---|---|---|---|---|
| WorxInvest NV | 35.44% | 13,044,532 | - | Largest shareholder (no % change provided) |
| The Vanguard Group, Inc. | 2.58% | 949,792 | €41.2 million | +0.5% |
| Dimensional Fund Advisors LP | 1.85% | 682,749 | €29.6 million | +4.45% |
| Norges Bank Investment Management | 1.48% | 544,553 | €23.6 million | No change |
| BlackRock, Inc. | 0.98% | 359,401 | €15.6 million | +111% |
| Candriam, Société En Commandite Par Actions | 0.90% | 332,163 | €14.4 million | No change |
Key implications for investors and stakeholders:
- Governance: WorxInvest's 35.44% stake implies decisive influence on strategic direction, board composition and M&A/private equity exit pacing.
- Liquidity and volatility: Large passive holders (Vanguard, Norges) tend to dampen short-term volatility; large increases by active managers (BlackRock +111%, DFA +4.45%) can amplify trading flows during rebalances.
- Valuation anchoring: Institutional valuations shown above (aggregate lines) provide a quick snapshot of market capital committed by key holders - useful when modeling potential selling pressure or strategic support.
- Investor type mix: Combination of strategic anchor plus global asset managers supports both control stability and broad market access for Gimv's stock.
For a deeper company background tied to ownership and strategy, see: Gimv NV: History, Ownership, Mission, How It Works & Makes Money
Gimv NV (GIMB.BR) - Key Investors and Their Impact on Gimv NV (GIMB.BR)
Gimv NV's shareholder base combines a dominant strategic anchor investor with a mix of institutional holders whose changes in position signal varying degrees of conviction about the company's growth profile and governance. The headline numbers below reflect recent reported holdings and material shifts in stakes.| Investor | Reported Stake | Change in Holding | Implication / Impact |
|---|---|---|---|
| WorxInvest NV | 35.44% | - | Largest shareholder; significant influence on strategy, capital increases and share purchase decisions. |
| The Vanguard Group, Inc. | 2.58% | +0.50% (net increase) | Steady, low-turnover index/ETF exposure-signals stable passive-plus allocation. |
| Dimensional Fund Advisors LP | 1.85% | +4.45% (relative increase) | Active signal of conviction in Gimv's growth prospects; tactical accumulation. |
| Norges Bank Investment Management | 1.48% | 0.00% (no change) | Long-term, buy-and-hold posture consistent with sovereign wealth/investment horizon. |
| BlackRock, Inc. | 0.98% | +111% (more than doubled) | Material re-entry/scale-up from a major global asset manager-indicates renewed interest. |
| Candriam, Société En Commandite Par Actions | 0.90% | 0.00% (no change) | Consistent position reflecting steady conviction and low turnover. |
- WorxInvest NV (35.44%): Acts as the strategic anchor-its decisions on capital increases and direct share purchases materially shape Gimv's access to capital, board composition and M&A/portfolio strategy.
- Vanguard (2.58%): Incremental accumulation (+0.5%) consistent with passive/index-driven flows supporting share price stability.
- Dimensional (1.85%): A 4.45% rise in holdings points to active conviction in Gimv's medium-term value creation.
- Norges Bank (1.48%): Stable allocation suggests long-horizon endorsement without active trading or re-rating intent.
- BlackRock (0.98%): +111% change is a sizeable directional move from the largest asset manager-can attract additional liquidity and third-party validation.
- Candriam (0.90%): No change-consistent institutional exposure aligning with conservative portfolio management.
Gimv NV (GIMB.BR) Market Impact and Investor Sentiment
Gimv NV (GIMB.BR) commands notable market attention driven by solid fundamentals, attractive yield and clear positioning across growth themes. Market capitalization of €1.6 billion and a share price of €43.60 as of December 12, 2025 reflect persistent investor confidence following the company's strong fiscal performance and strategic portfolio allocation.- Market cap: €1.6 billion (12‑Dec‑2025)
- Share price: €43.60 (12‑Dec‑2025)
- Net income (FY 2024-2025): €219 million
- Net asset value (NAV) per share: €53.30
- Dividend yield: 5.96% (ex‑dividend date: 30‑Jun‑2025)
- Analyst Buy consensus: 82% with average price target €49.98
- Included in Euronext BEL ESG index since March 2023
- Income investors: attracted by the 5.96% yield and predictable dividend cadence (ex‑dividend 30‑Jun‑2025).
- Value investors: see NAV premium potential with NAV/price spread of ~22%.
- Growth/sector investors: target Gimv's exposure to high‑growth themes (Consumer, Sustainable Cities, Smart Industries, Healthcare, Life Sciences).
- ESG‑focused investors: participation boosted by inclusion in the Euronext BEL ESG index since March 2023.
- Analysts & momentum traders: influenced by 82% Buy consensus and average €49.98 price target signaling upside (~14.6% from €43.60).
| Metric | Value | Notes |
|---|---|---|
| Market Capitalization | €1.6 billion | Snapshot 12‑Dec‑2025 |
| Share Price | €43.60 | Closing price 12‑Dec‑2025 |
| Net Income (FY 2024-2025) | €219 million | Reported fiscal year result |
| NAV per Share | €53.30 | Company reported |
| Dividend Yield | 5.96% | Ex‑dividend 30‑Jun‑2025 |
| Analyst Buy % | 82% | Consensus across sell‑side coverage |
| Analyst Avg. Price Target | €49.98 | Implied upside ≈14.6% |
| ESG Index Inclusion | Euronext BEL ESG | Since March 2023 |
- Consumer: resilient revenue streams and brand roll‑ups.
- Sustainable Cities: urban infrastructure and circular economy plays.
- Smart Industries: Industry 4.0 and automation assets delivering recurring contracts.
- Healthcare & Life Sciences: clinical upside and licensing/exit potential.
Gimv NV (GIMB.BR) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.